On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...